Some studies have confirmed that CSF1R + macrophages are associated with poor survival of various tumor types (Zhang et al., 2012; Pedersen et al., 2014), so therapies targeting CSF1R-related signal transduction pathways such as CSF1R inhibitors have been proven effective against cancer (Cannarile et al., 2017). This evidence concerns the gene CSF1R and cancer.